Advertising
From Pink Slips to Silent Sidelining: Inside adland’s layoff and anxiety crisis
Mamaearth-parent firm Honasa Consumer reports loss of Rs 18.57 crore, sales down 7%
Honasa Consumer's total income stood at Rs 481.84 crore in Q2 FY 25- down 4,24 percent. The company's expenses were up by 9.1 percent to Rs 506.21 crore in the same period.
Mamaearth-parent firm Honasa Consumer registers 35% drop in profit in FY25
Mamaearth-parent firm Honasa Consumer Ltd reported a consolidated loss of Rs 18.57 crore during the second quarter (July and September) in FY 2025 on account of inventory correction. In the last fiscal, the personal care brand posted profit after tax of Rs 29.43 crore.
The revenue from the operation of Honsaa Consumer was down 6.9 percent to Rs 461.82 crore compared to Rs 461.82 crore in the same period last year.
The maker of brands like The Derma Co, and Aqualogica, witnessed a decline in EBITDA (earnings before interest, taxes, depreciation, and amortization) of 6.6 percent.
"In this quarter, we have taken strategic steps towards transitioning from super-stockists to direct distributors in the top 50 cities. This transition has impacted our revenue and profits, leading to a slowdown for Mamaearth," Honasa Consumer Chairman and CEO Varun Alagh said.
However, Alagh added that the realignment will also strengthen offline go-to-market (GTM) strategy in the quarters ahead, setting the stage for our next phase of growth.
Honasa Consumer's total income stood at Rs 481.84 crore in Q2 FY 25- down 4,24 percent. The company's expenses were up by 9.1 percent to Rs 506.21 crore in the same period.
SPOTLIGHT
From purpose-driven work and narrative-rich brand films to AI-enabled ideas and creator-led collaborations, the awards reflect the full spectrum of modern creativity.
Read More“Confusion creates opportunity for agile players,” Sir Martin Sorrell on industry consolidation
Looking ahead to the close of 2025 and into 2026, Sorrell sees technology platforms as the clear winners. He described them as “nation states in their own right”, with market capitalisations that exceed the GDPs of many countries.